Coya Therapeutics Inc (COYA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 38,340 | 32,627 | 5,934 | 4,340 | N/A |
| Receivables | N/A | 7,500 | N/A | N/A | N/A |
| TOTAL | $44,308 | $41,196 | $7,185 | $4,584 | $N/A |
| Non-Current Assets | |||||
| PPE Net | 39 | 66 | 93 | 121 | N/A |
| Other Non-Current Assets | 0 | 0 | 1,117 | 87 | 0 |
| TOTAL | $39 | $66 | $1,211 | $208 | $N/A |
| Total Assets | $44,347 | $41,262 | $8,396 | $4,792 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,588 | 1,156 | 1,815 | 858 | 0 |
| Accrued Expenses | 1,388 | 2,973 | 2,008 | 291 | N/A |
| TOTAL | $3,825 | $5,052 | $3,824 | $1,148 | $N/A |
| Non-Current Liabilities | |||||
| Deferred Revenues | 848 | 923 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 0 | 0 | 12,966 | 0 | 0 |
| TOTAL | $945 | $575 | $12,966 | $N/A | $N/A |
| Total Liabilities | $4,770 | $5,627 | $16,789 | $1,148 | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 16,725 | 14,543 | N/A | N/A | N/A |
| Common Shares | 2 | 1 | 0 | 0 | N/A |
| Retained earnings | -40,737 | -25,856 | -17,869 | -5,624 | N/A |
| Other shareholders' equity | 0 | -11 | 8,794 | 8,794 | 0 |
| TOTAL | $39,577 | $35,636 | $-8,394 | $3,644 | $N/A |
| Total Liabilities And Equity | $44,347 | $41,262 | $8,396 | $4,792 | $0 |